Carnitine palmitoyltransferase 1A deficiency
Jan. 02, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Galactose is metabolized into UDP-Gal, which is used as a precursor for the glycosylation of different macromolecules. UDP-Gal can be used as a building block for synthesis of N-glycans and O-glycans. Moreover, UDP-Gal can be used to synthesize keratan sulfate, a glycosaminoglycan that, along with N- and O-glycans, is an essential component of several extracellular proteoglycans. Additionally, UDP-Gal is used to glycosylate collagens. Lastly, UDP-Gal can be used to glycosylate lipids alone or in combination with other monosaccharides, generating glycolipids. Among glycolipids, several types of glyceroglycolipids, sulfoglycolipids, and glycerolipids contain galactose in their sugar moieties. (Source: Conte F, van Buuringen N, Voermans NC, Lefeber DJ. Galactose in human metabolism, glycosylation, and congenital metabolic diseases: time for a closer look. Biochim Biophys Acta Gen Subj 2021;1865[8]:129898. CC BY License, http://creativecommons.org/licenses/by/4.0.)